CN108295300A - 一种三姊妹卫生巾芯片的加工方法 - Google Patents
一种三姊妹卫生巾芯片的加工方法 Download PDFInfo
- Publication number
- CN108295300A CN108295300A CN201710017572.4A CN201710017572A CN108295300A CN 108295300 A CN108295300 A CN 108295300A CN 201710017572 A CN201710017572 A CN 201710017572A CN 108295300 A CN108295300 A CN 108295300A
- Authority
- CN
- China
- Prior art keywords
- dubbed
- dispersion liquid
- sisters
- dry
- processing method
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000003672 processing method Methods 0.000 title claims abstract description 18
- 239000006185 dispersion Substances 0.000 claims abstract description 40
- 239000007788 liquid Substances 0.000 claims abstract description 40
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 claims abstract description 21
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 claims abstract description 16
- 235000003097 Artemisia absinthium Nutrition 0.000 claims abstract description 16
- 240000001851 Artemisia dracunculus Species 0.000 claims abstract description 16
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 claims abstract description 16
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims abstract description 16
- 239000001138 artemisia absinthium Substances 0.000 claims abstract description 16
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims abstract description 16
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 claims abstract description 15
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 claims abstract description 15
- XEABSBMNTNXEJM-UHFFFAOYSA-N propagermanium Chemical compound OC(=O)CC[Ge](=O)O[Ge](=O)CCC(O)=O XEABSBMNTNXEJM-UHFFFAOYSA-N 0.000 claims abstract description 15
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims abstract description 14
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 240000007890 Leonurus cardiaca Species 0.000 claims abstract description 3
- 239000004745 nonwoven fabric Substances 0.000 claims description 25
- 239000000843 powder Substances 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 241000207925 Leonurus Species 0.000 claims description 12
- 241000245665 Taraxacum Species 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 10
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 239000008367 deionised water Substances 0.000 claims description 5
- 229910021641 deionized water Inorganic materials 0.000 claims description 5
- 239000004744 fabric Substances 0.000 claims description 5
- 150000002191 fatty alcohols Chemical class 0.000 claims description 5
- 239000007970 homogeneous dispersion Substances 0.000 claims description 5
- 229940051841 polyoxyethylene ether Drugs 0.000 claims description 5
- 229920000056 polyoxyethylene ether Polymers 0.000 claims description 5
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims 2
- 238000004945 emulsification Methods 0.000 claims 1
- 229910052709 silver Inorganic materials 0.000 claims 1
- 239000004332 silver Substances 0.000 claims 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 7
- 230000017531 blood circulation Effects 0.000 abstract description 6
- 210000004185 liver Anatomy 0.000 abstract description 6
- 206010013935 Dysmenorrhoea Diseases 0.000 abstract description 5
- 239000008280 blood Substances 0.000 abstract description 5
- 210000004369 blood Anatomy 0.000 abstract description 5
- 230000001954 sterilising effect Effects 0.000 abstract description 4
- 238000004332 deodorization Methods 0.000 abstract description 3
- 230000036039 immunity Effects 0.000 abstract description 3
- 210000003734 kidney Anatomy 0.000 abstract description 3
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 3
- 240000001949 Taraxacum officinale Species 0.000 abstract description 2
- 230000003213 activating effect Effects 0.000 abstract description 2
- 230000035790 physiological processes and functions Effects 0.000 abstract description 2
- 230000001151 other effect Effects 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 210000004291 uterus Anatomy 0.000 description 5
- 230000008569 process Effects 0.000 description 4
- 206010046788 Uterine haemorrhage Diseases 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- IQULGZQMMPRBLA-UHFFFAOYSA-N 2-carboxyethylgermanium Chemical compound OC(=O)CC[Ge] IQULGZQMMPRBLA-UHFFFAOYSA-N 0.000 description 2
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 208000037093 Menstruation Disturbances Diseases 0.000 description 2
- 206010027339 Menstruation irregular Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000002785 anti-thrombosis Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 208000034158 bleeding Diseases 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 208000006374 Uterine Cervicitis Diseases 0.000 description 1
- 206010046914 Vaginal infection Diseases 0.000 description 1
- 201000008100 Vaginitis Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000009102 absorption Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000000146 antalgic effect Effects 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229940121357 antivirals Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 206010008323 cervicitis Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000002279 cholagogic effect Effects 0.000 description 1
- 238000004581 coalescence Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/18—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing inorganic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/20—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/26—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/40—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
- A61L2300/104—Silver, e.g. silver sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/224—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials containing metals, e.g. porphyrins, vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/30—Compounds of undetermined constitution extracted from natural sources, e.g. Aloe Vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/426—Immunomodulating agents, i.e. cytokines, interleukins, interferons
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Botany (AREA)
- Zoology (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明公开一种三姊妹卫生巾芯片的加工方法，它是由羧乙基锗倍半氧化物、蒲公英、三姊妹、益母草、香附、艾草、银离子、复配成分散液为原料，经传统和现代科学精制而成，具有通经活络、暖宫、安胎、活血化瘀、促进血液循环、调节生理机能、杀菌、消炎、护肝肾、除臭、提高免疫力、减少痛经等功效。
Description
技术领域
本发明是关于一种三姊妹卫生巾芯片的加工方法，更具体地说，本发明是关于一种以羧乙基锗倍半氧化物、蒲公英、三姊妹、益母草、香附、艾草、银离子、复配成分散液为原料的新型的生物保健卫生巾芯片及其加工方法。
背景技术
目前市面上的各种卫生巾五花八门，品种繁多，但以羧乙基锗倍半氧化物、蒲公英、三姊妹、益母草、香附、艾草、银离子、复配成分散液配制加工成一种三姊妹卫生巾芯片的加工方法产品，倘未见过上市和相关报道。
发明内容
本发明是针对上述不足提从一种以羧乙基锗倍半氧化物、蒲公英、三姊妹、益母草、香附、艾草、银离子、复配成分散液为原料及其配制加工成一种三姊妹卫生巾芯片的加工方法产品。通过离子启动中草，在接触月经湿润后将产生活性功能，从而吸引空气中的微菌体并与菌体上的酶结合在一起，杀死细菌的新陈代谢及繁殖能力，湿度越高活性越强、杀菌就越强，从而又能促通经活络、暖宫、安胎、活血化瘀、促进血液循环、调节生理机能、杀菌、消炎、护肝肾、除臭、提高免疫力、减少痛经等妇科疾病。
本发明的目的是将通过下述技术方案予以实现。
1、本发明各组分组成比例为：
羧乙基锗倍半氧化物0.5-3％、蒲公英(干)1-3％、三姊妹(干)1-3％、益母草(干)1-3％、香附(干)1-3％、艾草(干)1-3％、银离子0.5-2％、复配成分散液95％-100.5％。
2、本发明的加工方法为：
步骤一：预处理
1、将蒲公英、三姊妹、益母草、香附、艾草分别洗净，切细，晒干或烘干至含水份1-5％，然后混合磨成200-500目细粉备用；
步骤二：复配成分散液
1、所述的复配成分散液，是将无色透明纳米银溶液2-5％、脂肪醇聚氧乙烯醚0.5-1％、海澡胶粉3-6％、去离子水90-100％经乳化机搅拌配制复配成分散液备用；
步骤三：混合复配成分散液
1、将预处理得的混合细粉与羧乙基锗倍半氧化物、银离子加入复配成分散液中用乳化机搅拌均匀制成混合复配成分散液备用；
步骤四：
1、将混合复配成分散液均匀地加入生产无纺布布原料中，再按无纺布正常的生产工序生产无纺布，将所生产的无纺布通过充磁机充磁，最后将充好磁的无纺布复卷成合适的直径分切成合适的宽、长度即制得一种三姊妹卫生巾芯片的加工方法产品。
本发明的有益效果是：
1、本发明是根据妇女月经的生理特点和根据生物和物理的反应，通过离子推动中草药作用，疏通经络，从而达到杀菌、消炎、除臭、提高免疫力，减少痛经等妇科疾病的产生。
2、本发明各组分中
羧乙基锗半氧化物：具有刺激造血系统，参与体内代谢、氧富集、清除自由基、延缓衰老，免疫调节等功能。因此，世界上的化学家、药理学家及营养学家赋予有机羧乙基锗半氧化物为“人类疾病克星”、“21世纪救命锗”。
蒲公英：消痛散结，治疗热菌、壅结于肌肉所致的痛肿疮毒，抗菌、抗毒菌、抗肿瘤、治热淋、涩痛、抗内毒、治疗多种炎症。现代药理研究：入肝胃两经，不但有清热解毒利尿通淋、消肿散结、健胃消炎和保肝利胆的功效，还有清热活血的功能。药理实验表明：有抑菌抗病毒、抗炎、抗氧化、抗血栓，改善血循环等。
三姊妹：祛风止痛、散瘀消肿、祛风散寒、化痰理湿、解毒消肿、保肝。
益母草：现代研究证明，具有抗血栓、利尿、抗诱变、兴奋子宫、抗炎镇痛、改善淋巴系统等多种药理作用；现代临床常用来治疗功能子宫出血，是我国民间的调经止血药，具有较强的子宫兴奋作用，能增强子宫收缩幅度、频度及张力。
香附：理气解郁，调经止痛，用于肝郁气滞、胸肋、腹腔胀痛、消化不良、月经不调、经闭痛经、寒疝、痛经，对子宫肌张力的弛缓作用。
艾草：治疗少腹冷痛、经寒不调、宫冷不孕、吐血呕血、崩漏红等，同时还具有通十二经、具有回阳、理气血、逐湿寒、止血安胎、消炎、杀菌、吸收血液渗出，尤其是入脾、肝、肾经，能散寒除湿、温经止血。对妇女虚寒月经不调、腹痛、崩漏有明显疗效，是一种妇科的良药。
银离子：治疗妇宫颈炎、宫颈糜烂、阴道炎、老年性阴道炎，具有抗菌生素及灭菌作用。一般的抗生素平均只能对6种病菌起到作用，但银离子能消灭650种病菌。银离子能消弱病菌体内做活力作用的酵素，因而能够防止副作用和病菌的耐性强化，根本上控制病菌的繁殖。
具体实施方式：
下面结合实施例对本发明作进一步的描述：
实施例一：
羧乙基锗倍半氧化物0.5％、蒲公英(干)1％、三姊妹(干)1％、益母草(干)1％、香附(干)1％、艾草(干)1％、银离子0.5％、复配成分散液95％，其加工方法为：
步骤一：预处理
1、将蒲公英、三姊妹、益母草、香附、艾草分别洗净，切细，晒干或烘干至含水份1-5％，然后混合磨成200-500目细粉备用；
步骤二：复配成分散液
1、所述的复配成分散液，是将无色透明纳米银溶液2-5％、脂肪醇聚氧乙烯醚0.5-1％、海澡胶粉3-6％、去离子水90-100％经乳化机搅拌配制复配成分散液备用；
步骤三：混合复配成分散液
1、将预处理得的混合细粉与羧乙基锗倍半氧化物、银离子加入复配成分散液中用乳化机搅拌均匀制成混合复配成分散液备用；
步骤四：
1、将混合复配成分散液均匀地加入生产无纺布布原料中，再按无纺布正常的生产工序生产无纺布，将所生产的无纺布通过充磁机充磁，最后将充好磁的无纺布复卷成合适的直径分切成合适的宽、长度即制得一种三姊妹卫生巾芯片的加工方法产品。
实施例二：
羧乙基锗倍半氧化物3％、蒲公英(干)3％、三姊妹(干)3％、益母草(干)3％、香附(干)3％、艾草(干)3％、银离子2％、复配成分散液100％，其加工方法为：
步骤一：预处理
1、将蒲公英、三姊妹、益母草、香附、艾草分别洗净，切细，晒干或烘干至含水份1-5％，然后混合磨成200-500目细粉备用；
步骤二：复配成分散液
1、所述的复配成分散液，是将无色透明纳米银溶液2-5％、脂肪醇聚氧乙烯醚0.5-1％、海澡胶粉3-6％、去离子水90-100％经乳化机搅拌配制复配成分散液备用；
步骤三：混合复配成分散液
1、将预处理得的混合细粉与羧乙基锗倍半氧化物、银离子加入复配成分散液中用乳化机搅拌均匀制成混合复配成分散液备用；
步骤四：
1、将混合复配成分散液均匀地加入生产无纺布布原料中，再按无纺布正常的生产工序生产无纺布，将所生产的无纺布通过充磁机充磁，最后将充好磁的无纺布复卷成合适的直径分切成合适的宽、长度即制得一种三姊妹卫生巾芯片的加工方法产品。
实施例三：
羧乙基锗倍半氧化物1％、蒲公英(干)1.5％、三姊妹(干)1.5％、益母草(干)1.5％、香附(干)1.5％、艾草(干)1.5％、银离子1％、复配成分散液96％，其加工方法为：
步骤一：预处理
1、将蒲公英、三姊妹、益母草、香附、艾草分别洗净，切细，晒干或烘干至含水份1-5％，然后混合磨成200-500目细粉备用；
步骤二：复配成分散液
1、所述的复配成分散液，是将无色透明纳米银溶液2-5％、脂肪醇聚氧乙烯醚0.5-1％、海澡胶粉3-6％、去离子水90-100％经乳化机搅拌配制复配成分散液备用；
步骤三：混合复配成分散液
1、将预处理得的混合细粉与羧乙基锗倍半氧化物、银离子加入复配成分散液中用乳化机搅拌均匀制成混合复配成分散液备用；
步骤四：
1、将混合复配成分散液均匀地加入生产无纺布布原料中，再按无纺布正常的生产工序生产无纺布，将所生产的无纺布通过充磁机充磁，最后将充好磁的无纺布复卷成合适的直径分切成合适的宽、长度即制得一种三姊妹卫生巾芯片的加工方法产品。
Claims (2)
1.一种三姊妹卫生巾芯片的加工方法，组成为：羧乙基锗倍半氧化物、蒲公英、三姊妹、益母草、香附、艾草、银离子、复配成分散液，其特征是：羧乙基锗倍半氧化物0.5-3％、蒲公英(干)1-3％、三姊妹(干)1-3％、益母草(干)1-3％、香附(干)1-3％、艾草(干)1-3％、银离子0.5-2％、复配成分散液95％-100.5％。
2.根据权利要求“1”所述的一种三姊妹卫生巾芯片的加工方法，其特征是所述的及配制加工方法为；
步骤一：预处理
1、将蒲公英、三姊妹、益母草、香附、艾草分别洗净，切细，晒干或烘干至含水份1-5％，然后混合磨成200-500目细粉备用；
步骤二：复配成分散液
1、所述的复配成分散液，是将无色透明纳米银溶液2-5％、脂肪醇聚氧乙烯醚0.5-1％、海澡胶粉3-6％、去离子水90-100％经乳化机搅拌配制复配成分散液备用；
步骤三：混合复配成分散液
1、将预处理得的混合细粉与羧乙基锗倍半氧化物、银离子加入复配成分散液中用乳化机搅拌均匀制成混合复配成分散液备用；
步骤四：
1、将混合复配成分散液均匀地加入生产无纺布布原料中，再按无纺布正常的生产工序生产无纺布，将所生产的无纺布通过充磁机充磁，最后将充好磁的无纺布复卷成合适的直径分切成合适的宽、长度即制得一种三姊妹卫生巾芯片的加工方法产品。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710017572.4A CN108295300A (zh) | 2017-01-11 | 2017-01-11 | 一种三姊妹卫生巾芯片的加工方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710017572.4A CN108295300A (zh) | 2017-01-11 | 2017-01-11 | 一种三姊妹卫生巾芯片的加工方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108295300A true CN108295300A (zh) | 2018-07-20 |
Family
ID=62871521
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710017572.4A Pending CN108295300A (zh) | 2017-01-11 | 2017-01-11 | 一种三姊妹卫生巾芯片的加工方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108295300A (zh) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110179586A (zh) * | 2019-05-28 | 2019-08-30 | 玉苏甫江·亚森 | 一种石榴皮抑菌卫生巾及其制备方法 |
| CN113332043A (zh) * | 2021-05-27 | 2021-09-03 | 长沙景运鸿达电子商务有限公司 | 一种暖宫卫生巾及其生产方法 |
| WO2025222868A1 (zh) * | 2024-04-24 | 2025-10-30 | 露乐健康科技股份有限公司 | 一种抑菌袪异味组合物以及功能芯片 |
-
2017
- 2017-01-11 CN CN201710017572.4A patent/CN108295300A/zh active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110179586A (zh) * | 2019-05-28 | 2019-08-30 | 玉苏甫江·亚森 | 一种石榴皮抑菌卫生巾及其制备方法 |
| CN113332043A (zh) * | 2021-05-27 | 2021-09-03 | 长沙景运鸿达电子商务有限公司 | 一种暖宫卫生巾及其生产方法 |
| WO2025222868A1 (zh) * | 2024-04-24 | 2025-10-30 | 露乐健康科技股份有限公司 | 一种抑菌袪异味组合物以及功能芯片 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107596574A (zh) | 一种用于祛寒暖宫和调理痛经用的护理片 | |
| CN101703668A (zh) | 防治盆腔炎的纳米银远红外抗菌芦荟纤维织物脐阴带 | |
| CN108295300A (zh) | 一种三姊妹卫生巾芯片的加工方法 | |
| CN204744632U (zh) | 一种远红外负离子蕲艾草本卫生巾 | |
| CN104208624A (zh) | 一种治疗宫寒的艾条 | |
| CN103751532A (zh) | 一种治疗妇科炎症的中药组合物及其制备方法 | |
| CN101461916A (zh) | 一种治疗妇科疾病的外用中药组合物及其制配方法 | |
| CN112870311A (zh) | 一种女性私密处抑菌水凝胶及使用方法 | |
| CN105012818A (zh) | 一种治疗妇科炎症的组合物及其制剂和制法 | |
| CN101829144B (zh) | 二氧化硅超微粉末的应用及一种用于治疗子宫颈炎的药物 | |
| CN106552078A (zh) | 一种多功能生物制剂 | |
| CN201076616Y (zh) | 一种妇用保健康栓丸 | |
| CN105106304A (zh) | 一种治疗妇科炎症的中药复方制剂及其制备方法 | |
| CN109260426B (zh) | 一种消癥散结止痛外用中药及其制备方法和应用 | |
| CN103877452B (zh) | 一种壳聚糖阴道冲洗液及其制备方法 | |
| CN101143174A (zh) | 一种治疗妇女宫颈糜烂的中药配方 | |
| CN110448615A (zh) | 一种用于治疗妇科炎症的中药组合物、药物及其制备方法 | |
| CN110742982A (zh) | 一种治疗妇科疾病的壮药组合物、壮药栓剂及其制备方法 | |
| CN102670976A (zh) | 保健妇康液 | |
| CN101601729A (zh) | 一种用于乳腺疾病的保健用品及其制备方法 | |
| CN111298207A (zh) | 一种抗敏消炎多功能避孕套 | |
| CN1274331C (zh) | 一种治疗尖锐湿疣的合剂 | |
| CN108403721A (zh) | 水石痔疮膏及其制备方法 | |
| CN115252738A (zh) | 一种具有抑菌止痒净味作用的组合物及其制备方法和应用 | |
| CN108969793A (zh) | 功能性卫生巾 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20180720 |